Amarin said it filed a patent infringement lawsuit against Hikma Pharmaceuticals and Hikma’s U.S. affiliate in the United States District Court in Delaware.
- The complaint alleges that Hikma has induced the infringement of three patents by making, selling, offering to sell and importing generic icosapent ethyl capsules in or into the United States
To view the source of this information click <-bsp-bb-link state="{"bbDocId":"QKMYJF3RXUKG","_id":"00000176-1c04-dc08-ab76-dff682750000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">here
To contact the reporter on this story:
<-bsp-person state="{"_id":"00000176-1c04-dc08-ab76-dff682770000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Hari Govind in San Francisco at hgovind@bloomberg.net
To contact the editor responsible for this story:
<-bsp-person state="{"_id":"00000176-1c04-dc08-ab76-dff682790000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Chakradhar Adusumilli at cadusumilli@bloomberg.net
© 2020 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.